Ecofibre Ltd Ordinary Shares EOF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- A$0.06
- Day Range
- A$0.06–0.07
- 52-Week Range
- A$0.06–0.35
- Bid/Ask
- A$0.05 / A$0.07
- Market Cap
- A$23.11 Mil
- Volume/Avg
- 15,352 / 83,832
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.73
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Ecofibre Ltd through its subsidiaries is engaged in three business lines including Ananda Health, Ananda Food and Hemp Black. Amanda Health includes Production and sale of hemp related nutraceutical products focused on the US. Ananda Food includes Production and sale of hemp related food products in Australia. Hemp Black includes the development of hemp related fibre products globally.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- —
- Website
- https://www.ecofibre.com
Comparables
Valuation
|
Metric
|
EOF
|
MYX
|
GTII
|
|---|---|---|---|
Price/Earnings (Normalized) | — | — | 43.74 |
Price/Book Value | 0.75 | 1.05 | 1.75 |
Price/Sales | 0.73 | 2.17 | 2.80 |
Price/Cash Flow | — | — | 11.40 |
Price/Earnings
EOF
MYX
GTII
Financial Strength
|
Metric
|
EOF
|
MYX
|
GTII
|
|---|---|---|---|
Quick Ratio | — | 1.15 | 1.62 |
Current Ratio | — | 1.61 | 2.72 |
Interest Coverage | — | −6.99 | 8.83 |
Quick Ratio
EOF
MYX
GTII
Profitability
|
Metric
|
EOF
|
MYX
|
GTII
|
|---|---|---|---|
Return on Assets (Normalized) | — | −16.16% | 3.06% |
Return on Equity (Normalized) | — | −31.76% | 4.55% |
Return on Invested Capital (Normalized) | — | −27.83% | 3.80% |
Return on Assets
EOF
MYX
GTII
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
MKKGY
| Merck KGaA ADR | Vbgkgrvsw | Zmkhzf | $70.9 Bil | |
ZTS
| Zoetis Inc Class A | Bbbjbxvrm | Tyxnq | $68.9 Bil | |
HLN
| Haleon PLC ADR | Gfthltxf | Pfh | $37.5 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Kzznvzqjz | Tnrp | $14.7 Bil | |
VTRS
| Viatris Inc | Zmgcfjvjk | Lvhb | $13.7 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Dfvbtnh | Hlcv | $11.9 Bil | |
CTLT
| Catalent Inc | Tctcyskl | Pcprb | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Rprplwwz | Gxtl | $4.1 Bil | |
CURLF
| Curaleaf Holdings Inc | Gqyvshs | Dmqz | $3.6 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Xqtlbsw | Fjggkj | $3.5 Bil |